Recent Posts
- Lessons learned from my most recent sickle cell pain crisis
- SCD patients free of VOEs after treatment with gene-editing therapy
- Etavopivat may reduce VOC rate, increase hemoglobin in SCD
- Why it’s important to celebrate good care when we receive it
- Most patients free of vaso-occlusive crises for years after Casgevy dose
- The difficult reality of dealing with invisible sickle cell complications
- Most SCD patients given Lyfgenia in trials stay free of VOEs: New data
- How I cope with cold weather as someone with sickle cell disease
- Kanglin raises $20M to advance sickle cell gene therapy KL003
- Trial of gene-editing therapy into SCD’s cause opens in California